First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product
On Wednesday, the FDA approved Verona Pharma plc’s (NASDAQ:VRNA) Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. Ohtuvayre is ...
Wakefield Express on MSN
COPD clinical trial: Mid Yorkshire Teaching NHS Trust recruits first patient to new COPD clinical trial
Mid Yorkshire Teaching NHS Trust has become the first site in Europe to recruit a patient to a major international clinical ...
Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal. The deal gives Merck access to Verona Pharma’s new chronic ...
FILE - The logo for Merck appears above a trading post on the floor of the New York Stock Exchange, Thursday, May 1, 2025. (AP Photo/Richard Drew, File) (Richard Drew ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback